Pfizer will stop selling poultry-pumping drug: US
June 8, 2011 by Kerry Sheridan
The pharmaceutical giant Pfizer will voluntarily suspend US sales of a poultry-pumping additive after studies showed it can leave traces of arsenic in chicken livers, the US government said on Wednesday.
The Food and Drug Administration said the move followed a recent study of 100 broiler chickens which found that those treated with the animal drug 3-Nitro, or Roxarsone, had higher levels of inorganic arsenic in their livers than untreated chickens.
The levels detected were "very low" and do not pose a health risk, the FDA said.
The drug is marketed by Alpharma, a subsidiary of Pfizer, and has been used since the 1940s to ward off infection, make chicken skins more yellow and boost the birds' growth.
"FDA detected increased levels of inorganic arsenic in the livers of chickens treated with 3-Nitro, raising concerns of a very low but completely avoidable exposure to a carcinogen," said Michael Taylor, FDA deputy commissioner for foods.
"We are pleased to announce that the company is cooperating with us to protect the public health."
The order will take effect in 30 days.
The FDA approved 3-Nitro in 1944, when it became the first arsenic-containing new animal drug product approved by the US regulatory agency.
It is fed mainly to chickens but is also used for swine and turkeys. Most of its sales are in the United States, though US regulators said they would share their findings with international governments.
Arsenic-based food additives are banned in Europe, according to an industry newsletter published by the Netherlands-based Worldpoultry.net.
Perdue, a major chicken producer in the United States, said it has not used Roxarsone in several years and saw no decline in flocks' health.
"Perdue does not use Roxarsone or arsenic. We phased out the use of this animal health feed additive in April 2007 as we improved our flock health and management programs," spokesman Joe Forsthoffer said in an email to AFP.
"We've found that, through improved flock health programs and housing environments, we are able to produce healthy chickens without it."
Pfizer and Alpharma representatives could not immediately be reached for comment.
The National Chicken Council, which said it represents 95 percent of chicken producers and processors in the United States, issued a statement saying that consumers need not change their buying or eating habits.
"3-Nitro has been used to maintain good health in chicken flocks for many years. It is used in many, but not all, flocks," the council statement said.
"Consumers can continue to buy and eat chicken as they always have."
Some poultry farmers use 3-Nitro to ward off coccidiosis, a parasitic disease that attacks an animal's intestines. It also helps chickens gain weight and gives a golden color to their skin.
Alpharma said on its website that Roxarsone is a "non-antibiotic feed additive that helps increase the rate of weight gain and improve feed efficiency of pigs by promoting a healthy gut."
The arsenic in Roxarsone is organic, according to Alpharma.
However the chickens were found to have inorganic arsenic, the poisonous kind, in their organs, according to FDA research.
The study of toxicity in chicken livers began after researchers showed that organic arsenic could change form.
"Published scientific reports have indicated that organic arsenic, a less toxic form of arsenic and the form present in 3-Nitro, could transform into inorganic arsenic," the FDA statement said.
A coalition of consumer groups filed a federal lawsuit last month against the FDA over the use of human antibiotics in animal feed, saying it creates dangerous superbugs.
The suit alleges that the regulatory agency concluded in 1977 that the practice of feeding healthy animals low doses of penicillin and tetracycline could lead to the rise of antibiotic-resistant bacteria in people, but continues to allow it anyway.
Roxarsone was not included in the suit because it is not an antibiotic.
(c) 2011 AFP
-
From lemons to lemonade: Reaction uses carbon dioxide to make carbon-based semiconductor,
32 comments
-
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments,
3 comments
-
SpaceX private rocket blasts off for space station (Update),
42 comments
-
Climate scientists say they have solved riddle of rising sea,
31 comments
-
SpaceX capsule has 'new car' smell, astronauts say (Update),
2 comments
-
Potential Breakthrough in Seizure Control
May 26, 2012
-
Popping/Cracked sternum.
May 25, 2012
-
Which Mental Illness Encompasses This Problem?
May 25, 2012
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Keep food safety in mind this memorial day weekend
(HealthDay) -- Picnics, parades and cookouts are as much a part of Memorial Day weekend as tributes to the United States' war veterans.
14 hours ago |
not rated yet |
0
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Medicine & Health / Alzheimer's disease & dementia
23 hours ago |
not rated yet |
0
Color-changing contact lenses to help diabetics (w/ Video)
For the millions of Americans with diabetes, the inconvenient and often painful method of testing blood sugar levels is a way of life. But research and innovative product design by scientists at The University of Akron may ...
May 23, 2012 |
4.4 / 5 (7) |
4
|
Missouri opts for untested drug for executions
(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...
Medicine & Health / Medications
May 24, 2012 |
not rated yet |
4
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
May 24, 2012 |
4.7 / 5 (40) |
3
|
Nvidia trumpets Tegra 3 phone design wins for 2012
(Phys.org) -- Nvidias competitive war paint has a name, Tegra 3. On the heels of Nvidia announcements about lowering costs of its Tegra 3 processors and Nvidia-enabled tablets running Android Ice Cream ...
Browser wars flare in mobile space
The browser wars are heating up again, but this time the fight is for dominance of the mobile Internet.
Scientist: Evolution debate will soon be history
(AP) -- Richard Leakey predicts skepticism over evolution will soon be history. Not that the avowed atheist has any doubts himself.
Dell tablet leak: 10.1-inch display, two-battery choice
(Phys.org) -- Headline after headline talks about vendors tablets in the wings as likely number-one contenders for the iPad. Such claims have justifiably been taken with a grain of salt, considering ...
Social welfare cuts ultimately come with heavy price, researchers say
(Phys.org) -- Slashing government funding for Medicaid, food stamps and other programs that serve the poor while politically popular with some lawmakers and many conservatives may do more harm ...
Is a classical electrodynamics law incompatible with special relativity?
(Phys.org) -- The laws of classical electromagnetism that were developed in the 19th century are the same laws that scientists use today. They include Maxwell’s four equations along with the Lorentz la ...